Better Coronavirus Stock: Moderna vs. Novavax
New cases of the coronavirus disease COVID-19 are cropping up all around the world. With thousands of deaths from the disease, drugmakers both big and small are scrambling to develop an effective vaccine.
Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) stand out as two of the leaders in this race to develop a COVID-19 vaccine. Which of these two coronavirus-focused biotech stocks is the better pick for investors? Here's how Moderna and Novavax stack up against each other.
Image source: Getty Images.
Source Fool.com
